A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer.
| Autor: | Asakawa, Jumpei, Iguchi, Taro, Tamada, Satoshi, Yasuda, Sayaka, Ninomiya, Noriko, Kato, Minoru, Yamasaki, Takeshi, Ohmachi, Tetusji, Nakatani, Tatsuya |
|---|---|
| Zdroj: | Basic & Clinical Andrology; 7/18/2018, Vol. 28 Issue 1, pN.PAG-N.PAG, 1p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink